Shaw J, Jorba J, Zhao K, Iber J, Chen Q, Adu F
J Virol. 2018; 92(9).
PMID: 29444940
PMC: 5899205.
DOI: 10.1128/JVI.01949-17.
Kanduc D, Fasano C, Capone G, Pesce Delfino A, Calabro M, Polimeno L
J Immunol Res. 2015; 2015:541282.
PMID: 26568962
PMC: 4629041.
DOI: 10.1155/2015/541282.
Borley D, Mahapatra M, Paton D, Esnouf R, Stuart D, Fry E
PLoS One. 2013; 8(5):e61122.
PMID: 23667434
PMC: 3646828.
DOI: 10.1371/journal.pone.0061122.
Sasaki A, Haraguchi Y, Yoshida H
Front Microbiol. 2012; 3:178.
PMID: 22783231
PMC: 3390584.
DOI: 10.3389/fmicb.2012.00178.
Sandager M, Nugent J, Schulz W, Messner R, Tam P
Virology. 2007; 372(1):35-47.
PMID: 18029287
PMC: 2352162.
DOI: 10.1016/j.virol.2007.10.020.
Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.
Tam P, Weber-Sanders M, Messner R
J Virol. 2003; 77(21):11849-54.
PMID: 14557670
PMC: 229355.
DOI: 10.1128/jvi.77.21.11849-11854.2003.
Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein.
Ramsingh A, Lee W, Collins D, Armstrong L
J Virol. 1997; 71(11):8690-7.
PMID: 9343227
PMC: 192333.
DOI: 10.1128/JVI.71.11.8690-8697.1997.
Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
Fiore L, Ridolfi B, Genovese D, Buttinelli G, Lucioli S, Lahm A
J Virol. 1997; 71(9):6905-12.
PMID: 9261417
PMC: 191973.
DOI: 10.1128/JVI.71.9.6905-6912.1997.
Molecular basis for serological cross-reactivity between enteroviruses.
Samuelson A, Forsgren M, Johansson B, Wahren B, Sallberg M
Clin Diagn Lab Immunol. 1994; 1(3):336-41.
PMID: 7496972
PMC: 368258.
DOI: 10.1128/cdli.1.3.336-341.1994.
Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II.
Murdin A, Wimmer E
J Virol. 1989; 63(12):5251-7.
PMID: 2479772
PMC: 251190.
DOI: 10.1128/JVI.63.12.5251-5257.1989.
Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.
Gritz L, Destree A, Cormier N, Day E, Stallard V, Caiazzo T
J Virol. 1990; 64(12):5948-57.
PMID: 2243381
PMC: 248768.
DOI: 10.1128/JVI.64.12.5948-5957.1990.
Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.
Delpeyroux F, Van Wezel E, Blondel B, Crainic R
J Virol. 1990; 64(12):6090-100.
PMID: 2173781
PMC: 248783.
DOI: 10.1128/JVI.64.12.6090-6100.1990.
Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
Ren R, Moss E, Racaniello V
J Virol. 1991; 65(3):1377-82.
PMID: 1847458
PMC: 239915.
DOI: 10.1128/JVI.65.3.1377-1382.1991.
Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.
Kitson J, Burke K, Pullen L, Belsham G, Almond J
J Virol. 1991; 65(6):3068-75.
PMID: 1709696
PMC: 240962.
DOI: 10.1128/JVI.65.6.3068-3075.1991.
Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.
Wiegers K, Wetz K, Dernick R
J Virol. 1990; 64(3):1283-9.
PMID: 1689392
PMC: 249245.
DOI: 10.1128/JVI.64.3.1283-1289.1990.
Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis.
Wiegers K, Dernick R
J Virol. 1992; 66(7):4597-600.
PMID: 1376371
PMC: 241275.
DOI: 10.1128/JVI.66.7.4597-4600.1992.
Identification of T-helper epitopes in the VP1 capsid protein of poliovirus.
Kutubuddin M, Simons J, Chow M
J Virol. 1992; 66(5):3042-7.
PMID: 1373200
PMC: 241064.
DOI: 10.1128/JVI.66.5.3042-3047.1992.